Glaukos Submits Supplemental PMA for iStent Infinite

September 7, 2021

0 Views

The iStent infinite is designed for use in a standalone procedure to reduce elevated intraocular pressure in patients with open-angle glaucoma uncontrolled by prior surgical or medical therapy.

Glaukos Submits Supplemental PMA for iStent Infinite

Emulate's Organ-on-Chip Technology in the 2nd Inning, Still Has Room to Grow

Pain Points When Maintaining a Cleanroom
Manufacturing Durable Diabetes Tech for the 21st Century
Innovation in Patient Monitoring and Wearables
More Layoffs Signal COVID-19 Testing Boom Is Over
Increasing COVID Numbers in China Creates Uncertainty
High-Quality (Level 4) PMCF Surveys: What Are They?

Glaukos Submits Supplemental PMA for iStent Infinite

Medtech in a Minute: Elizabeth Holmes Heads to Trial, Baxter Bets Big on Hillrom, and More

Emulate's Organ-on-Chip Technology in the 2nd Inning, Still Has Room to Grow